| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter serves as a Chief Commercial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 27 sells. Those positions are worth an estimated $8.3M at current prices.
Historically, Heerma Peter's trades have earned a middling insider score of 53/100 across 21 rated trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -26.6%.
The biggest single holding is TVTX (~$8.3M) as Chief Commercial Officer. The recent filings there lean toward selling, a net 74,545 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,250 | $31.50 | $70,863.75 | -1.8% | |
| Feb 3, 2021 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,126 | $29.83 | $33,588.58 | -1.0% | |
| Oct 5, 2020 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,376 | $19.13 | $83,691.00 | -4.8% |